BOILERPLATE TEXT FOR GRANT APPLICATIONS

Greater Los Angeles Consortium

The Greater Los Angeles CTSA Consortium was established to leverage our local talents in collaborations that benefit both our local communities and our approaches to clinical research. The two main activities that are currently underway are (a) a Community Engagement working group that is developing and evaluating an intervention with promotoras to increase Latino representation in clinical trials research, and (b) a series of training opportunities offered by each consortium member for faculty and staff of the other members' institutions. Our collective goal is to collaborate to develop curricula and online courses that can ultimately be shared with the national consortia online while supporting collaborative efforts across the Greater Los Angeles area through onsite, in-person programs and seminars.

Curricula underway or in development include: UCLA's Biomedical Informatics for Clinicians course and the Therapeutic Discovery and Development program, UC Irvine's Science of Team Science Boot Camp and Introduction to Systems Biology for Clinical Translational Scientists course, and USC's Regulatory Science for Clinical Research Boot Camp, Engaging Diverse Communities in Clinical Research Boot Camp and Regulatory Science Boot Camp.

Last updated July 1, 2018

The CTSI Grant Library has over 70 successful award applications that are accessible to all CTSI investigators and designees. Sample application types include: F32, K01, K08, K23, K24, K99/R00, R01, diversity supplements and U54 applications. Users request access to the library and use a UCLA Logon ID which can be obtained without a UCLA affiliate.

Last updated October 16, 2020

The UCLA Department of Neurology has a library of grant applications accessible to UCLA personnel through UCLA Box (login required). For assistance, contact Laura Saade.

Last updated October 16, 2020

The Harold and Pauline Price Center for Entrepreneurship & Innovation is a recognized leader in entrepreneurial education and research at the UCLA Anderson School of Management. Working closely with its board of advisors, the Price Center fosters the study and practice of entrepreneurship and business innovation by providing the foundation on which creativity can flourish and individuals can succeed.

The UCLA Anderson School of Management and the Price Center work together to provide a challenging, interdisciplinary curriculum for students who intend to embrace global and integrationist thinking, work across boundaries, and muster an uncommon amount of courage to pursue their entrepreneurial vision. First-hand experience in an entrepreneurial environment is vital to the success of our curriculum. The Price Center funds numerous fellowships designed to afford students real-world business experiences. To encourage entrepreneurial research, the Price Center has established programs such as the Galef Symposium in Business Innovation, which supports the research of Ph.D. students, academic researchers and faculty whose projects demand an openness to flexibility and new ideas, a predisposition to study innovative methods, and a capacity to see beyond existing paradigms. The Price Center also maintains a strong commitment to serving the nonprofit and small business communities through management development programs and topical seminars. All of these efforts aim to foster the study and practice of entrepreneurship and business innovation. Join us and make true impact

Last updated July 1, 2018

Since its establishement in 1981, the Knapp Venture Competition has evolved into one of the premier academic business plan competitions in Southern California. It encourages UCLA Anderson students to showcase their talents and learn from insights of successful entrepreneurs and business executives. The Knapp Competition has given more than 1,800 UCLA Anderson students a unique venture creation experience that has been instrumental in launching numerous businesses. Over the course of the academic year, UCLA Anderson students refine business concepts, build management teams, and develop business plans to submit to the Knapp Venture Competition. A select group of business plans are chosen for competition in the semifinals, with the top submissions advancing to the finals in May. The judging panels, which are comprised of entrepreneurs, venture capital investors and senior executives, play a critical role in shaping the outcome and educational experience of the competition. Our judges ask questions to evaluate each entry's viability, and also provide students with constructive feedback and suggestions for going forward with their ventures. After a closed deliberation, the Knapp finalists are announced at a reception.

Last updated July 1, 2018

UCLA Technology Development Group serves as a campus-wide gateway to Innovation, Research and Entrepreneurship. Their mission is to:

• Promote UCLA innovation, research, teaching and entrepreneurship to benefit society
• Create economic value to support UCLA’s scholarly and educational missions and the State of California
• Lead UCLA’s research community to bring innovation to market

The scope of activities include:

• Commercially evaluating new technologies
• Determining patentability and commercial value
• Prosecuting patents
• Marketing and licensing inventions
• Facilitating UCLA faculty startups
• Engaging industry to facilitate research collaboration
• Negotiating license agreements and Material Transfer Agreements
• Receiving and distributing royalties and other income to the inventors, UCLA Campus and its Departments

Last updated July 1, 2018

UCLA Ventures is a community of entrepreneurs and venture capitalists who support each other, the university, and its entrepreneurial ecosystem. Using a unique pledge mechanism, Ventures has built a portfolio of leading UCLA-backed startups. As a community, they support these companies, as well as the entrepreneurs behind them. With the returns from the portfolio, Venture fosters UCLA’s entrepreneurial ecosystems through programming, volunteerism, and financial distributions to key initiatives on campus.

Last updated July 1, 2018

NIH MD2K (Mobile Data to Knowledge) Center of Excellence, or MD2K, is one of 12 national Big Data Centers of Excellence awarded by the National Institutes of Health (NIH) as part of its Big Data-to-Knowledge initiative. The MD2K Center brings together leaders in computer science, engineering, medicine, behavioral science, and statistics from 13 universities (Cornell Tech, Georgia Tech, Harvard, Northwestern, Ohio State, Rice, UCLA, UC San Diego, UC San Francisco, the University of Massachusetts Amherst, the University of Memphis, the University of Michigan and West Virginia University), and Open mHealth (a non-profit organization). The MD2K Team develops innovative tools to make it easier to gather, analyze and interpret health data generated by mobile and wearable sensors. MD2K’s goal is to develop big data solutions that reliably quantify physical, biological, behavioral, social, and environmental factors that contribute to health and disease risk. The MD2K Team aims to lay the scientific foundations for turning the wealth of mobile sensor data available through new and rapidly evolving wearable sensors into reliable and actionable health information, and contribute to the vision of predictive, preventive, personalized, participatory, and precision (P5) medicine.

Last updated July 1, 2018

The Los Angeles Pediatric Research Integrating Sensor Monitoring Systems (LA PRISMS) Center is fostering the development and application of mobile health (mHealth) technologies that deepen our scientific understanding and clinical management of pediatric conditions. Bringing together leading experts from UCLA and USC in biomedical informatics, computer science, wireless health, environmental science and health, and pediatrics, this Center focuses on the creation of innovative end-to-end software infrastructure for pediatric sensor-based health monitoring. A part of the NIH's Pediatric Research Integrating Sensor Monitoring Systems (PRISMS) community, this collaborative effort focuses on pediatric asthma. Our Center's vision and proposed research is motivated by the following question: what if you could predict ahead of time, for a specific asthma patient, the potential for exacerbation and thus mitigate–if not prevent–the event? Any system with this ability must integrate the growing array of available physiologic and environmental data from sensors, and place such data into context to elucidate the patient's state and specific situation. The system must be able to act sufficiently quickly on sensed data to make timely recommendations, and end user compliance with system usage must be high to effect change. Our solution, the Biomedical REAl-Time Health Evaluation for Pediatric Asthma (BREATHE) platform, provides an extensible framework for the deployment of data collection protocols; secure data collection from sensors to a mobile device; integration of additional contextual information; and real-time analysis.

Last updated July 1, 2018

The ACT Network is a nationwide federation of leading academic research institutions that share aggregate patient counts from electronic health record data. Its development is funded by the NIH through the National Center for Advancing Translational Sciences (NCATS) and the Clinical and Translational Science Award (CTSA) program. It contains over 40 million patient records, and by the end of 2018 included ~60% of the CTSA consortium. The ACT Network queries the total numbers of patients at each participating site meeting your inclusion or exclusion criteria for demographics (age, gender, race, etc.), diagnoses (ICD9/10 codes), lab results, and most frequently prescribed medications. Not all data points are available for all patients. ACT helps clinical investigators conduct cohort discovery before a trial starts, to establish feasibility of a clinical protocol for grant applications, IRB submission, etc. ACT also helps investigators identify additional sites for a clinical trial. By allowing investigators to thoroughly explore patient cohorts and potential sites before finalizing their clinical protocols, ACT increases the odds of successfully completing clinical trial recruitment.

Last updated April 15, 2019

Amazon Web Services (AWS) is a broad set of commercial computing, storage, database, analytics, application, and deployment services. AWS is used by the UC locations to host websites and web applications, provide backup and disaster recovery, support high bandwidth computing services, and more. As of February 2017, UCLA is an Amazon Web Service (AWS) Educate Institution. AWS Educate is Amazon’s global initiative to provide students and educators with the resources needed to greatly accelerate cloud-related learning to help prepare students for a cloud-enabled workplace. AWS Educate provides four pillars of grant-based support for educators and students: 1) content on the Cloud contributed by top educators and AWS to help build courses; 2) training materials to better understand AWS; 3) collaboration tools such as discussion forums, events, and places to upload and rate content; and 4) credits to access AWS services for free.

Last updated January 31, 2019

The California Health Interview Survey (CHIS) is the largest state health survey in the nation and is conducted by the UCLA Center for Health Policy Research in collaboration with the California Department of Public Health and the Department of Health Care Services. It is a random-dial telephone survey that asks questions on a wide range of health topics. CHIS is conducted on a continuous basis allowing the survey to generate timely one-year estimates. More than 20,000 Californians--including adults, teenagers and children--are interviewed each year, and several years of data can be combined to create an even larger sample. Participants in the CHIS survey are chosen at random and the sample is extensive enough to be statistically representative of California's diverse population. As an example, in 2013-2014, more than 48,000 Californians in each county were surveyed, including 3,484 households in Los Angeles County (3,350 adults and 660 children). Out of these households in LA County, CHIS estimated that around 600 were below the poverty level, ~600 are African American and ~1,500 are Hispanic. Thus, although the sample sizes are not enormous for each disparity population, analysis of the CHIS can provide a window for health metrics for prevalent conditions and for the larger special populations – children, elderly, and some disparity populations (African-Americans and Hispanics). The survey provides: statewide information on the overall population including many racial and ethnic groups, county-level information for most counties to aid with health planning, priority setting, and to compare health outcomes in numerous ways, plus ZIP code, city and legislative district information via their online web tool, AskCHIS Neighborhood Edition (NE). CHIS is conducted by the UCLA Center for Health Policy Research in collaboration with the California Department of Public Health and the Department of Health Care Services.

Last updated July 1, 2018

eMERGE is a national network organized and funded by the National Human Genome Research Institute (NHGRI) that combines DNA biorepositories with electronic medical record (EMR) systems for large scale, high-throughput genetic research in support of implementing genomic medicine. In its projects, eMERGE studies and pilots genomic medicine translation through discovery, implementation, tools, and policy. During Phase I and II, the Network deployed more than 40 electronic phenotype algorithms across more than 55,000 participants with dense genomic data. Returning clinical results has been implemented or planned for pilot at sites across the Network. A large-scale survey of patient attitudes regarding data sharing is being sent to 90,000 clinic patients across the country. A multicenter pilot of returning genome sequence information to electronic medical records (EMRs) for use in healthcare is almost complete. Themes of genomics, bioinformatics, genomic medicine, ethnics, data sharing, privacy, and community engagement are of particular relevance to eMERGE.

eMERGE was initiated in 2007 and included five biorepositories linked to EMRs. The network demonstrated that EMR phenotyping to develop cohorts for genome-wide studies was a robust approach to genetic discovery, defined approaches for enhancing privacy of shared EMR data, and engaged patients and communities in consent and data sharing. eMERGE expanded to include 7 clinical sites in 2011 and 2 pediatric sites in 2012.

eMERGE is openly interested in collaborations. Current external collaborations include the US Air Force, ENCODE, IGNITE, and the larger ELSI (Ethical, Legal, and Social Issues) community. eMERGE is dedicated to developing tools, identifying best practices, and communicating results for participant consent, data sharing, and returning genomic research results, to benefit the broader medical and scientific communities and the general public.

Last updated July 1, 2018

The GATK Best Practices provide step-by-step recommendations for performing variant discovery analysis in high-throughput sequencing (HTS) data. There are several different GATK Best Practices workflows tailored to particular applications depending on the type of variation of interest and the technology employed. The Best Practices documentation attempts to describe in detail the key principles of the processing and analysis steps required to go from raw reads coming off the sequencing machine, all the way to an appropriately filtered variant callset that can be used in downstream analyses. Wherever we can, we try to provide guidance regarding experimental design, quality control (QC) and pipeline implementation options, but please understand that those are dependent on many factors including sequencing technology and the hardware infrastructure that are at your disposal, so you may need to adapt our recommendations to your specific situation.

Last updated July 1, 2018

The high performance computing (HPC) organization within the UCLA Institute for Digital Research and Education (IDRE) has been supporting scientific computing on the UCLA campus since the early 1960s. Advanced research has moved beyond the capacity of a single computer for detailed multi-level simulations, data analysis, and large-scale computations. Because of the increasing complexity and requirement for sheer computational horsepower, these needs are increasingly met with tightly integrated cluster systems consisting of hundreds to hundreds of thousands of processors, terabytes to petabytes of high-performance storage, and high bandwidth/low latency interconnects consuming megawatts of power. In addition to the need for powerful hardware, the software that runs on these systems must be written to take advantage of the computational power available on a particular system. This is the domain of High-Performance Computing (HPC). The IDRE-HPC group is a strong team of experienced researchers in High Performance Computing. The group provides its expertise and support to empower scholars in their abilities to compute on high-end computer systems. IDRE-HPC also supports the Hoffman2 shared cluster and manages the IDRE Cluster Hosting Program for UCLA researchers. These resources meet campus needs for small- to medium-sized cluster computing and may provide a starting point to resources at national computing centers.

• Hoffman2. UCLA’s Shared Hoffman2 Cluster has 64-bit nodes, currently 774 and 7,508 cores, with an Ethernet network and Infiniband interconnect, that includes a scheduler, GCC and the best performing compiler for C, C++, Fortran 77, 90 and 95 on the current Shared Cluster architecture, applications and software libraries that offer languages, compilers and software specific to Chemistry, Chemical Engineering, Engineering, Mathematics, Visualization, Programming and an array of miscellaneous software. The current peak performance of the cluster is in order of 75 Trillion Floating Point, double precision, operations per second (TFLOPS). Hoffman2 is currently the largest and most power cluster in the University of California system. Additional resources for researchers include complete system administration for contributed cores, cluster access through a 10Gb network interconnect to the campus backbone, high performance home and scratch storage space, capability to run large parallel jobs that can take advantage of the cluster’s InfiniBand interconnect, and web access to the Hoffman2 Cluster through the UCLA Grid Portal, and access to the BlueArc and Panasas storage systems. The cluster is also an end point on Globus online service using 10Gb network interconnect backbone, thus providing researchers a facility for fast and reliable data movement between Hoffman2 and most leadership class facilities across USA.
• Dawson2 Cluster. UCLA’s Dawson2 GPU CLuster, ranked 148 in the Top500, comprises 96 HP ProLiant SL390 G7 systems, each having dual socket Intel Xeon X5650 processors, 3 Nvidia M2070 Graphics processors, and 48 GB of main memory giving peak performance of 1.66 double precision Trillion Floating Point operations per second (TFLOPS). The cluster uses QDR Infiniband networking and 160 Terabytes of high performance common disk space from Panasas for communication and storage respectively.

Last updated July 1, 2018

The Informatics for Integrating Biology & the Bedside (i2b2) Cohort Discovery System contains data from 2.5 million unique patients at UCLA. i2b2 is a secure online tool designed for UCLA investigators to conduct searches on clinical data from Ronald Reagan UCLA Medical Center, Santa Monica UCLA Medical Center and other UCLA-affiliated clinics and departments. The search results provide a numeric count of patients that are based on de-identified data extracted from UCLA’s clinical data warehouse. Search criteria include demographics, diagnosis and procedure codes (ICD-9, ICD-10 and CPT), labs, medications, visit details (including site locations), vital signs and vital status.

Last updated April 15, 2019

Los Angeles Data Resource (LADR) is a joint project of major Los Angeles healthcare provider organizations, including UCLA, Cedars-Sinai (CSMC), Charles Drew University (CDU), USC, Children’s Hospital Los Angeles (CHLA) and the City of Hope, aimed at enabling research that improves the health of all people in the region using data representing the continuum of care across the region’s major health systems. LADR allows investigators to conduct interactive searches across the participating organizations on patient demographics, diagnosis and procedure codes (ICD-9, ICD-10 and CPT), labs, medications, visit details, vital signs and vital status and will be available to you and your research team for recruitment purposes for your study. LADR formally launched in May 2014 with two organizations, University of California, Los Angeles (UCLA) and Cedars-Sinai Medical Center (CSMC). Since then, Keck Medical Center of USC and City of Hope have also gone live, and investigators can now search a total of 6.6 million patient records. Charles R. Drew University of Medicine and Science has joined the LADR consortium and will become functional in the near future.

Last updated April 15, 2019

Qualtrics is an online tool available to the UCLA CTSI for generating surveys, processing data, and creat-ing reports for sharing findings. This online survey platform is HIPAA and FERPA compliant. Qualtrics provides support, user guides, and training to research staff.

Last updated February 1, 2021

The University of California Data Warehouse (UCDW) provides an integrated, universal source for reporting, analytics and business intelligence. Functioning as an analytical data warehouse, it stores historical institutional data sourced from University of California campuses transactional databases via flat files and enrichment data from external educational bodies and boards, such as California Department of Education (CDE) and IPEDS. Data taken from campuses directly may not necessarily match information provided to the CDE or IPEDS. These agencies have various definitions for reporting that are not initially stored in source systems, and thus are not necessarily imported into the data warehouse. The enrichment data will be utilized for comparative analysis and as such, are sourced at aggregated levels.

The vision of the UC data warehouse is for this repository to be the source of authorized information around student, staff, faculty, budget and staff data. This data warehouse will be accessible by university executives, faculty, staff, administrators and researchers. It is expected that this analytical enterprise data source will provide UC with the following benefits:

• Tools To Combine Data Differently – The data warehouse environment will give users a tool for looking at data differently. This tool allows decision makers to ask new questions and an opportunity to solve problems differently. This benefit is related to reporting and its associated tools. 
• End User Empowerment – The warehouse will empower institutional decision makers by placing inquiry and analysis tools at their fingertips. 
• Timely Information Access – The data warehouse will shorten the time span between user reporting data needs and information delivery, giving decision makers instant access to historical (static) data through the use of ad-hoc query and reporting tools. 
• Future Vision From Historical Trends – The data warehouse will provide the data needed for effective business analysis which includes forecasting and trending using historical multiple academic years, or terms, worth of data using various points in time—snapshots. 

Subject areas currently available include Student Enrollment, Course Enrollment, Degree, Undergraduate Enrollment, Contracts and Grants, Climate Survey, UCUES, and Payroll/Personnel.

Last updated January 31, 2019

UCLA’s Integrated Clinical and Research Data Repository (xDR) is OHIA’s large scale clinical data warehouse that supports data analyses and extractions for research as well as analytics to support clinical quality management functions of the UCLA Health System. The xDR contains data derived from multiple clinical systems including a full copy of the CareConnect Clarity data warehouse, which is linked to disease registry data, other data from systems in Radiology, Pathology and other departments, and “legacy” data from older outpatient and hospital billing and managed care systems. The UCLA CTSI serves as the “storefront” for research access to xDR data.

Last updated April 15, 2019

Biomathematics 170A. Introductory Biomathematics for Medical Investigators. (4) Lecture, three hours; discussion, one hour. Intensive elementary statistics course emphasizing design and applications to observational studies and experiments/clinical trials. Statistical topics include study design, descriptive statistics, elementary probability and distributions, confidence intervals and hypothesis testing, sample size and power, linear regression and correlation, analysis of variance, nonparametric statistics. Applications to biomedical literature and design of clinical trials. Letter grading.

Last updated June 1, 2020

Biomathematics 259. Controversies in Clinical Trials. (2) Lecture, one hour; discussion, one hour. Preparation: completion of professional health sciences or M.D. degree. Required of all MS in Clinical Research students. Discussion and analysis of eight published and well-known trials with students, one invited clinical faculty member, and course director. Development of critical ability to evaluate trial design and pitfalls. S/U or letter grading.

Last updated June 1, 2020

Biomathematics M260A-M260B. Methodology in Clinical Research I, II. (4-4) Lecture, four hours. Recommended preparation: M.D., PhD, or dental degree. Requisites: courses 170A, 265A. Course M260A is requisite to M260B. Presentation of principles and practices of major disciplines underlying clinical research methodology, such as biostatistics, epidemiology, pharmacokinetics. S/U or letter grading.

Last updated June 1, 2020

Biomathematics M260C. Methodology in Clinical Research III. (4) (Same as Medicine M260C.) Discussion, four hours. Recommended preparation: M.D., PhD, or dental degree. Presentation of principles and practices of major disciplines underlying clinical research methodology, such as biostatistics, epidemiology, pharmacokinetics. S/U or letter grading.

Last updated June 1, 2020

Biomathematics M261. Responsible Conduct of Research Involving Humans. (2) (Same as Medicine M261.) Lecture, two hours; discussion, two hours. Preparation: completion of one basic course in protection of human research subjects through Collaborative Institutional Training Initiative. Discussion of current issues in responsible conduct of clinical research, including reporting of research, basis for authorship, issues in genetic research, principles and practice of research on humans, conflicts of interest, Institutional Review Board (IRB), and related topics. S/U or letter grading.

Last updated June 1, 2020

Biomathematics M262. Communication of Science. (2) (Same as Psychiatry M230.) Lecture, two hours; discussion, one hour. Presentation of various types of scientific writings and their good practice. Details of writing specific articles: methods, results, discussion. Writing of review article. Grant submissions: aims, background, results, design. Role of appendices. Communication with lay public. S/U or letter grading.

Last updated June 1, 2020

Biomathematics 264. Applied Data Collection and Analysis. (4) Lecture, four hours. Presentation of research project development, including protocol development, data collection, quality control, clinical/electronic health record (EHR) data, structuring data for analysis, and data archival. Lectures, in-class practicums using actual studies and datasets, and student presentations. Letter grading.

Last updated June 1, 2020

Biomathematics 265A. Data Analysis Strategies I. (4) Lecture, two hours; laboratory, two hours. Preparation: MD or PhD degree. Requisite: course 170A. Designed to provide students with hands-on experience developing and testing hypotheses using various types of databases. Topics include developing testable hypothesis, data management, and analysis strategies and written presentation of findings. Experience with full process of hypothesis generation, operationalization of variables, selection of analysis techniques, and presentation of findings so students are better prepared to complete data analysis, interpretation of results, and written presentation of their findings (e.g., for master’s thesis and subsequent articles). Students encouraged to provide their own data. Databases provided for use in completing exercises for those without available data. Letter grading.

Last updated June 1, 2020

Biomathematics 266A. Applied Regression Analysis in Medical Sciences. (4) Lecture, three hours; laboratory, one hour. Requisite: course 170A. Proficiency in applied regression analysis, with focus on interpretation of results and performing computation. Primary topics include simple linear regression, multiple regression, regression model selection, analysis of variance, logistic regression, and survival analysis. Letter grading.

Last updated June 1, 2020

Biomathematics 266B. Advanced Biostatistics. (4) Lecture, three hours; discussion, one hour. Requisite: course 266A. Continuation of course 266A. Some traditional multivariate methods, such as principle components, factor analysis, cluster analysis, and more contemporary methods, including recursive partitioning and missing data. Multilevel and longitudinal analysis. Letter grading.

Last updated June 1, 2020

Biomathematics 285. Introduction to High-Throughput Data Analysis. (4) Seminar, three hours. Requisites: courses M260A, M260B. Introduction to high-throughput data analysis, including DNA microarray technologies and next- generation sequencing technology. Presentation of statistical methods and software for handling complex data produced by experiments using these technologies. Some hands-on training on data analysis provided. S/U or letter grading.

Last updated June 1, 2020

Biomathematics 596. Directed Individual Study or Research in Biomathematics. (2 to 12) Tutorial, to be arranged. Individual study on topics not yet covered by offerings of department. May be repeated for credit with topic change. S/U or letter grading.

Last updated June 1, 2020

The Clinical Trials Administration Office (CTAO) has the authority to negotiate and execute agreements that meet the UCLA definition of a clinical trial and when it is funded by a pharmaceutical, device, biotech company, or for-profit Clinical Research Organization (CRO) whether directly of through another academic medical center or non-profit organization (i.e. Pfizer to Yale to UCLA). A Clinical Research Study at UCLA is more broadly defined to include research such as retrospective chart reviews and analysis of existing medical data. The Office of Contract and Grant Administration has the authority to negotiate and execute agreements for clinical research studies and clinical trials funded by the government or a non-profit entity.

Last updated July 1, 2018

Established by the Chancellor in the mid-1980s, the Conflict of Interest Review Committee (CIRC) is a peer review panel composed of faculty from a broad cross section of academic disciplines throughout campus. The CIRC is responsible for reviewing personal financial interests disclosed by UCLA researchers, making determinations about whether those outside financial interests constitute conflicts of interest, and making recommendations about how those conflicts of interest can be eliminated, reduced, or managed so that research awards can be accepted and work can commence. In this role, the CIRC serves as the substantive independent review committee required under the State of California Political Reform Act and as the “designated official(s)” required under federal policy/regulation on financial conflicts of interest related to research.

Last updated July 1, 2018

The UCLA Institutional Biosafety Committee (IBC) was established as the local review body responsible for oversight of all research activities – including teaching laboratories – involving the use of hazardous biological material and recombinant or synthetic nucleic acids, as required and outlined in the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) and the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL). The IBC is a faculty-led committee appointed by the UCLA Vice Chancellor for Research (VCR) and consists of experts in various fields, including biosafety, human gene therapy, infectious disease, recombinant DNA, animal containment, plant containment, and occupational health. The IBC is responsible for establishing, monitoring, and enforcing policies and procedures involving hazardous biological materials and recombinant/synthetic nucleic acids to meet applicable federal, state, local and institutional regulations and guidelines.

The IBC reviews and approves protocols for academic research and teaching laboratories involving the following materials: recombinant/synthetic nucleic acid molecules, as covered by the NIH Guidelines; infectious agents that can cause disease in healthy humans and/or significant environmental or agricultural impacts, as covered by the BMB; select agents and select toxins, as covered by the CDC DSAT regulations; human and nonhuman primate materials, as covered by the Cal/OSHA Bloodborne Pathogen Standard; genetically-modified animals and whole plants, as covered by the NIH Guidelines. At its discretion, the IBC may also review protocols involving animals or animal specimens known to be reservoirs/vectors of zoonotic diseases.

Last updated July 1, 2018

The UCLA Office of Clinical Research (OCR) provides services aimed at accelerating the entire clinical research process. The Office serves the UCLA Health system, and the services provided help navigating the process from industry-sponsored contracting to IRB submission and reliance to study activation support. In order to deliver these comprehensive services, the Office of Clinical Research is comprised of six groups, including: Coordination Services & Education (CSE); Financial Coverage & Activation (FCA); Clinical Research Informatics Systems (CRIS); Clinical Trial Contracts & Sponsor Relations (CTC-SR); Office of Regulatory Affairs (ORA); and Embedded Clinical Research Innovation (ECRI).

Coordination Services & Education (CSE). CSE is a resource within the OCR that assists UCLA faculty, staff, and clinical research teams with the regulatory, financial and compliance-related components of clinical research during study activation, conduct, and closeout of a clinical trial. CSE includes three dedicated teams focused on advancing contributions in study activation, study conduct and study team training and education.

Financial Coverage & Activation (FCA). The Financial Coverage & Activation (FCA) team within the Dean’s Office School of Medicine and the Clinical and Translational Science Institute (CTSI) provides a centralized performance of Coverage Analysis at UCLA (Health System). Nationally recognized as a thought-leader and best practice model for coverage analysis, FCA provides services that include the development of compliant clinical research budgets pursuant to Federal, State, and local laws and regulations as well as to UCOP and UCLA policies. Additionally, the FCA mitigates clinical research billing compliance risk, particularly those associated with multi-million dollar settlements with the federal government. 4c. Regulatory Coordinator Services.

Clinical Research Information Systems (CRIS). UCLA Clinical Research Informatics Systems (CRIS) leverages technology in concert with workflow re-engineering to ensure efficient, compliant and nimble clinical research business processes. CRIS produces transparent and actionable business metrics, provides business support and analytics, as well as system configuration, data management/migration, and workflow re-engineering. Other functions include training and end-user support. Additionally, the CRIS team manages and maintains OnCore, which is a clinical trials management system (CTMS) used at UCLA for the management of clinical trials in clinical research. The system maintains and manages planning, performing and reporting functions at the study and subject level along with participant contact information, tracking deadlines and milestones. The use of OnCore enables the study team to set up and manage all protocols and subjects in one place, supports clinical research billing, simplifies data management and monitoring , improves patient recruitment and tracking and automates the flow of information between UCLA based systems including WebIRB, PATS and CareConnect. The CRIS team works collaboratively with Financial Coverage and Activation, Clinical Research Business Partners (CRBP) and Research Connect team members to provide a variety of data solutions and operation management tools for clinical research teams.

Clinical Trial Contracts & Sponsor Relations (CTC-SR). The Clinical Trial Contracts & Sponsor Relations (CTC-SR) negotiates Industry Supported Clinical Trial Agreements for the Health System. Services include negotiating compliant terms and conditions for clinical trial agreements, outbound subcontracts, master agreements, and confidentiality agreements for both sponsor-initiated and PI-initiated clinical trials. Additionally, the CTC-SR ensures clinical trials are performed in accordance with applicable law through arm’s length negotiations with industry; manages perceived conflicts of interest and/or bias in the conduct of studies; ensures fair and equitable treatment of resulting University Intellectual Property; manages risk amongst contracting parties; provides consultation, guidance, and advice to faculty and staff on applicable law, University policies, and University business norms related to the conduct of clinical trials; and ensures all necessary internal approvals are in place prior to contract execution.

Office of Regulatory Affairs (ORA). The Office of Regulatory Affairs (ORA) provides a broad spectrum of support for clinical investigators and their study teams in the conduct and navigation of clinical research regulatory requirements. Services provided by this office include: Scientific and Feasibility Review, Data and Safety Monitoring, internal monitoring and auditing support, FDA and Sponsor inspection/audit preparation and guidance, ClinicalTrials.gov registration and results reporting assistance, FDA IND/IDE guidance and support, regulatory binder preparation, and more. The mission of the ORA is to guide and support the UCLA clinical research community through the different compliance requirements associated with the conduct of clinical research. 

To see OCR services and programs, see the boilerplates "CTSI-supported collaborations and initiatives" section.  

Last updated June 1, 2020

The UCLA Office of Contract and Grant Administration (OCGA) assists the campus research community in reviewing, approving and submitting proposal applications and negotiating and executing contracts and grants from government and non-profit sponsors. OCGA has primary responsibility for the interpretation of University-wide and campus policy, sponsor guidelines, and applicable federal and state laws and regulations related to governmental and non-profit sponsored activities. OCGA also executes all outgoing Subawards issued under grants or collaborative agreements.

Last updated July 1, 2018

The Office of the Human Research Protection Program (OHRPP) is the administrative arm of the UCLA Human Research Protection Program (HRPP). The OHRPP in partnership with the research community is responsible for ensuring the safety and welfare of participants in Human Research Projects conducted under the aegis of UCLA. The OHRPP, which is a Division within the Office of Research Administration, provides the campus and the five UCLA Institutional Review Boards (IRBs) with professional guidance and administrative support.

Last updated July 1, 2018

The primary role of the Office of Research Administration (ORA) is to provide the campus with professional guidance and administrative support for all sponsored research activities. ORA maintains accurate records and administrative oversight of research projects and ensures proper administration of contracts and grants awarded to CTSI researchers at UCLA through the following mechanisms: Office of Contract and Grant Administration (OCGA), Office of Research Policy and Compliance (ORPC), Extramural Fund Management (EFM), Office for the Protection for Research Subjects (OHRPP) and Research Safety and Animal Welfare (RSAWA).

Last updated July 1, 2018

Reporting to the Vice Chancellor and Chief Financial Officer, the Office of Academic Planning and Budget (APB) supports UCLA executive management and campus-level strategic planning by providing objective and timely data and analysis to inform central and unit decision making processes. It acts in an advisory role to the Chancellor and Executive Vice Chancellor/Provost in the allocation and administration of all campus funds. In addition, the office interacts with the Office of the President (OP) to ensure that the campus resource base and its flexibility are maximized and that the campus academic performance and programs are accurately characterized in systemwide reports. Working with academic units, APB also plays a key role in providing guidance and support at the programmatic level. APB compiles data from official campus sources and generates institutional information and analyses used by the college, schools, and departments in program planning and resource management. Institutional data are also provided to accrediting organizations, federal departments, the state legislatures, and ranking agencies as part of the accountability reporting schedule.

Last updated July 1, 2018

The UCLA Institutional Review Boards (IRBs) are the committees designated by UCLA to review the conduct of research involving human subjects that is conducted by UCLA faculty and staff (conducting studies involving human subjects within the course and scope of their duties) as well as UCLA students (conducting studies involving human subjects within the course of their studies). The function of the IRBs is to ensure adherence to all federal, state, local, and institutional regulations concerning the protection of human subjects in research. UCLA IRB review is required for both funded and non-funded human subjects research. University policy requires all non-UCLA investigators wishing to access any UCLA facilities, patients, or personnel (faculty, staff or students) for human subjects research to submit an Application for Administrative Review to the UCLA OHRPP for confirmation that the research does not require UCLA IRB review or Certification of Exemption from UCLA IRB review.

The five UCLA IRBs are supplemented by multiple arrangements for accepting the reviews of external IRBs. The UCLA Office of the Human Research Protection Program (OHRPP) provides support to the UCLA IRBs and for arrangements with external IRBs.

Last updated July 1, 2018

UCLA Technology Development Group serves as a campus-wide gateway to Innovation, Research and Entrepreneurship. Our mission is to: promote UCLA innovation, research, teaching and entrepreneurship to benefit society, create economic value to support UCLA’s scholarly and educational missions and the State of California and lead UCLA’s research community to bring innovation to market. The scope of activities include: commercially evaluating new technologies, determining patentability and commercial value, prosecuting patents, marketing and licensing inventions, facilitating UCLA faculty startups, engaging industry to facilitate research collaboration, negotiating license agreements and Material Transfer Agreements as well as receiving and distributing royalties and other income to the inventors, UCLA Campus and its departments.

Last updated July 1, 2018

CareConnect is UCLA's electronic health record (EHR) program. The system integrates functions of approximately 65 software applications into a single system accessible across the health system and is available around-the-clock to clinical faculty and staff members. Services include scheduling, registration, referrals, and authorizations for UCLA managed care members at all clinics, clinical applications - pharmacy, Computerized Provider Order Entry (CPOE), documentation, radiology, rounding lists - at all hospitals, Computerized Provider Order Entry (CPOE) and documentation at a group of clinics and procedure areas in our hospitals (Wave 0), and CareConnect Lite as a replacement for cView at all clinics (except those in Wave 0).

An estimated 18,000 faculty and staff members use CareConnect, including physicians, pharmacists, nurses, advanced-practice nurses, other clinicians, trainees, students, and staff members working with scheduling, registration, billing, patient placement (ADT), and hospital information management (HIM). The CareConnect program is led by a team with expertise in EHR implementation and deep institutional knowledge of our health system. The CareConnect program is overseen by an Executive Oversight Board composed of leaders from UCLA Health System and David Geffen School of Medicine, which developed 11 principles to guide development and implementation of CareConnect.

Last updated July 1, 2018

Harbor-UCLA Medical Center is a Level 1 Trauma Center with an NIH-funded General Clincal Research Center. The 72-acre facility is composed of the 8-story, 553-bed hospital, and a 52,000 square foot Primary Care and Diagnostic Center in addition to a complex of buildings, wooden barracks, and trailers. The on-campus the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, with an annual budget of over 50 million dollars, provides extensive laboratory and administrative facilities for faculty investigators. Other buildings on the campus include the St. John's Cardiovasular Research Center, the Walter P. Martin Research Building, the Professional Office Building, the Imaging Center, and the A.F. Parlow Library of the Health Sciences. The total building space is approximately 1,000,000 square feet.

All of the approximately 300 full-time faculty as well as some of the more than 450 part-time and voluntary professional staff hold faculty appointments at the UCLA School of Medicine. They devote their time to the clinical care of patients, research, and teaching at Harbor-UCLA Medical Center. The nearly 450 residents and fellows training at Harbor also contribute to these endeavors. The hospital sponsors 34 Accreditation Council for Graduate Medical Education accredited residency and fellowship programs as well as other graduate medical training programs. The hospital also serves as a major training site for medical students from the David Geffen School of Medicine at UCLA and the Charles R. Drew University of Medicine and Science.

The emergency room has been enlarged and a number of special care units have been constructed from what were formerly ward rooms. In 1994, the 50,000 square foot Edward J. Foley Primary Care and Diagnostic Center was opened. Over the years the hospital and medical programs of the facility have grown and improved steadily.

Last updated July 1, 2018

Information Services & Solutions (ISS) develops and maintains the central technology infrastructure and provides services and applications to over 20,000 people comprising UCLA Health, Practice Group and School of Medicine. We are committed to delivering progressive technology solutions that effectively support the patient care, research, and teaching missions of the Health Sciences and offer an increasingly integrated set of computing and communication services. We serve more than a fixed collection of hospitals, clinics, classrooms, labs, and offices, and strive to bring UCLA expertise to the community by participating in health exchanges and investing in technologies that shorten distances between people such as real-time access to information, telemedicine services, and web based access to resources.

Last updated July 1, 2018

The Pediatric Neuromuscular Disease Clinic meets twice a month and the majority of patients seen are B/DMD. Additional patients with SMA, myotonic dystrophy, congenital muscular dystrophy are seen on select clinic days. The clinic can accommodates patients for multidisciplinary visits. Most B/DMD patients are seen two times per year for routine care and more frequently when needed. Physicians available in the multidisciplinary clinic include medical specialists (neurology, genetics, cardiology) - board certified pediatricians, neurologists, neurology fellows, and pediatric and adult neurology residents. The clinic is able to serve both adult and pediatric patients and Dr. Perry Shieh is fully credentialed to provide specialist services to both children and adults. Older patients who need fewer of the child related services (i.e. Child-life specialist) are seen in multidisciplinary clinic or on another day depending on insurance coverage and needs. Drs. Stan Nelson and Nancy Halnon are both board certified pediatricians who can evaluate for disease or treatment related complications and manage steroid dependent patients in conjunction with primary care physicians.

Last updated July 1, 2018

The Stewart and Lynda Resnick Neuropsychiatric Hospital at UCLA is among the leading centers in the world for comprehensive patient care, research and education in the fields of mental health, developmental disabilities and neurology. It is the major psychiatry teaching facility of the David Geffen School of Medicine at UCLA and Ronald Reagan UCLA Medical Center, one of the nation’s top-ranked medical centers. The hospital is an independently accredited and licensed hospital located on the fourth floor of the Ronald Reagan UCLA Medical Center, with its own entrance and address. The hospital was named in honor of Stewart and Lynda Resnick, whose generous donation through the Resnick Family Foundation supported the construction of the neuropsychiatric hospital. The hospital’s vision is to serve the healthcare needs of the community, its patients and their families through excellence in research, education and the delivery of neuropsychiatric and behavioral health services. By the numbers, Resnick: ranked No. 7 in the nation in psychiatry by U.S. News & World Report; has 74 inpatient beds, is 75,020 square feet, and has an average length of stay of 12.83 days. Patients of all ages with psychiatric illnesses and developmental disabilities receive innovative treatment and compassionate care. Team members include specialists in psychiatry, neurology, medicine and pediatrics, as well as nursing, psychology, occupational therapy, recreational therapy, speech pathology, social work and special education. Treatment is tailored to by age group: the child and adolescent care program, the adult inpatient care program and the geriatric program.

Last updated July 1, 2018

Founded in 1955, UCLA Medical Center became Ronald Reagan UCLA Medical Center in 2008, reopening in a new 10-story structure (eight above ground) that takes hospital design to a new level. The latest medical advances are provided in a welcoming environment that is filled with light and open spaces to enhance a sense of wellness and promote healing. Situated on four acres on the UCLA campus in West Los Angeles, the hospital encompasses Ronald Reagan UCLA Medical Center, Stewart and Lynda Resnick Neuropsychiatric Hospital at UCLA and UCLA Mattel Children's Hospital. This was one of the first total replacement hospital projects to be built in accordance with the latest California seismic safety requirements. Every floor of Ronald Reagan UCLA Medical Center is dedicated to a particular specialty and equipped with all of the necessary support equipment and supplies. Every floor has its own satellite pharmacy, dialysis storage, respiratory therapy workrooms, and resident doctor sleep rooms. In addition, each patient room has the capacity to convert into an intensive care unit (ICU) to allow for the continuous care of a critically ill patient in one room.

As the primary teaching hospital for the David Geffen School of Medicine, the 520-bed, 1,050,000 square foot medical center provides patient care in nearly all medical specialties. According to US News & World Report, UCLA Health hospitals are rated Best in the West for 27 consecutive years, number one in Los Angeles, and as one of the top seven hospitals in the United States. Furthermore, the medical center has Magnet Status for Nursing Excellence, is a national leader in organ transplantation, has 25 operating rooms, and receives over 50,000 emergency patients annually.

Key hospital features include: surgical suites with full audiovisual integration systems and leading-edge medical equipment; a GONDA Observation Unit run by a hospitalist team--a special short-stay unit for patients requiring observation for a specific symptom; The BirthPlace, Westwood allows mothers to give birth and recover in-a comfortable, home-like setting that easily and quickly transforms into an efficient operating room for the delivery; a Level 1 trauma center with multiple trauma rooms and a dedicated-CT scanner enables doctors to more immediately diagnose patients upon their arrival; intensive care units employ a "line of sight" approach that ensures 360-degree access to critically ill patients; and room service food delivery allows patients to personalize their menu orders and arrange for their delivery at a convenient time.

Last updated July 1, 2018

UCLA’s Compliance Program enhances the University’s duty to perform its public responsibilities in an ethics and compliance-based environment where legal, regulatory, Regental, UC policy and other compliance requirements are followed and in which the public trust is maintained. The goal of the compliance program is to provide guidance and address compliance concerns across campus. The Compliance Program has an Oversight Committee on Audit, IT Governance, Compliance, and Controls and is a standing committee composed of campus leadership responsible for providing policy direction and oversight regarding campus-wide accountability and compliance matters. The committee is supported by the UCLA Ethics and Compliance Officer with collaboration from various campus partners.

Last updated July 1, 2018

The UCLA Dental Clinics in Westwood and the UCLA Venice Dental Center are the patient care branches of the UCLA School of Dentistry. Since UCLA is an educational institution, a number of the procedures and policies differ from a private practice. While patient care is always the foremost concern, the clinics are equally responsible for the education and training of our students and residents. Before becoming a patient at a clinic, a patient will first be screened by a faculty member to determine if the treatment needs are a good fit for the teaching environment. A full series of X-rays or basic X-rays will be taken as needed, determined by the screening faculty. Once the screening process is complete and the patient is accepted as a potential teaching case in a student clinic, he/she will be scheduled for a comprehensive oral examination to assess the general state of their oral health and create a full-mouth treatment plan.

Last updated July 1, 2018

UCLA Health is a self-supporting non-profit organization, owned and operated by the Regents of the University of California, to support the clinical activities of the professional schools of dentistry, medicine, nursing and public health. UCLA Health is comprised of: the Ronald Reagan UCLA Medical Center (520 beds); the Mattel Children’s Hospital (131 beds); the Stewart and Lynda Resnick Neuropsychiatric Hospital at UCLA (74 beds); the UCLA Medical Center, Santa Monica (281 beds); UCLA Health Clinics; UCLA Faculty Group; and the David Geffen School of Medicine. Additionally, the Westwood campus includes the Jules Stein Eye Institute and Doris Stein Eye Research Center, the Semel Institute for Neuroscience and Human Behavior Neuropsychiatric Institute, and the UCLA Jonsson Comprehensive Cancer Center, one of over 70 NCI-designated comprehensive cancer centers. Outpatient facilities include a six-story, 380,000-square-foot ambulatory care center housing the Family Health Center for primary care of routine illnesses; the Children's Health Center; Internal Medicine clinics; a Surgery Center; and a 104,000 square foot building housing the outpatient, training and research programs of the Stewart and Lynda Resnick Neuropsychiatric Hospital and the Jane and Terry Semel Institute for Neuroscience and Human Behavior. This building also houses the UCLA Medical Center rehabilitation program.   

UCLA Health boasts 3,200 total faculty, of which 3,050 are clinical faculty and 150 are basic science faculty. UCLA Health also boasts 1,300 residents and fellows as well as 3,800 registered nurses, part of a net total of 32,000 employees. More than 300 UCLA physicians are listed among the best doctors in America, with many ranked as Super Doctors. Altogether, UCLA Health hospitals and clinics have over 2.8 million annual outpatient visits, with nearly 670,000 unique patients per year, and UCLA Health sustains 36,000 hospital stays and 73,000 Emergency Department visits per year.   

A unique feature of UCLA is the presence of the Center for the Health Sciences (CHS) complex (one of the largest health-science centers in the country) that includes a hospital, School of Medicine, School of Dentistry, School of Nursing, School of Public Health, and California NanoSystems Institute on the same campus as the Division of Life Sciences and 7 other professional schools. This centralized complex ensures that all UCLA investigators have offices and/or a lab well within a close walking distance. 

For more than 60 years, UCLA Health has provided the best in health care and the latest in medical technology to the people of Los Angeles and throughout the world. A self-supporting non-profit organization, owned and operated by the Regents of the University of California, UCLA Health’s mission is to deliver leading-edge patient care, research, and education, and its vision is to heal humankind, one patient at a time, by improving health, alleviating suffering and delivering acts of kindness. As an academic medical center, UCLA Health is able to offer patients the latest technologies as well as access to potentially life-saving new therapies and leading-edge clinical trials. With a comprehensive array of research and clinical centers, addressing topics from stem cell biology, AIDS, gene therapy, neurosciences, women's health and geriatrics, UCLA continues to define what an academic medical center can be.  

Last updated March 18, 2022

UCLA Mattel Children's Hospital cares for the physical and emotional well-being of children, from newborns to young adults. With a dedicated entrance from Gayley Avenue, UCLA Mattel Children's Hospital is located on the third and fifth floors of Ronald Reagan UCLA Medical Center. UCLA's facilities are designed to serve the most critically ill children with sophisticated, compassionate care in an environment that is both welcoming and healing to children and their families. In 1998, Mattel Children's Foundation, a philanthropic arm of Mattel, Inc., pledged $25 million toward construction of the hospital. In 2017, Mattel, Inc. made a $50-million gift to The UCLA Foundation to benefit children’s health. With Mattel's support, UCLA Mattel Children's Hospital will expand pediatric services locally; broaden its global presence to enhance and improve the health of children worldwide; and promote the global sharing of UCLA Health’s best practices and research. In total Mattel has 131 inpatient beds, which includes 44 beds in the pediatric unit, 22 beds in the neonatal ICU, 18 beds in the pediatric ICU and 6 beds in the pediatric cardiac ICU. The Mattel Children’s Unit at UCLA Medical Center, Santa Monica includes a 25-bed Pediatric Unit—with four beds dedicated to acutely ill children—and a 16-bassinet high-tech, high-touch Neonatal Intensive Care Unit. Each nursing unit has its own minor procedure room so young patients can undergo certain treatments away from their sleeping area to avoid associating pain or distress with their own room.

Last updated July 1, 2018

UCLA Medical Center, Santa Monica serves as the cornerstone of UCLA Health's Santa Monica medical campus. The 265-bed, full-service medical center provides the complete continuum of healthcare services, from prenatal and neonatal care to geriatric medicine, in a technologically advanced and welcoming facility. It combines the expertise of an academic medical center with the accessibility of a community hospital to offer patients the best of both medical worlds. The medical center features several outstanding programs and services on or near its 4.5-acre medical campus. These include: the Nethercutt Emergency Center, which treats nearly 50,000 patients annually and serves as Santa Monica's only Emergency Department (ED) approved for pediatric care; The BirthPlace, one of Southern California’s most comprehensive maternity centers, where approximately 1,500 babies are delivered each year; a 25-bed Pediatrics Unit, which operates as a unit of UCLA Mattel Children's Hospital and serves as Santa Monica's only inpatient unit for pediatric care; the UCLA Rape Treatment Center and its Stuart House facility for sexually abused children serve as national models for the treatment of rape victims and their families; the UCLA Breast Center, Santa Monica, located within the UCLA medical building, provides personalized, multi-disciplinary breast care in a compassionate and supportive environment; UCLA Radiology which performs state-of-the-art imaging services in several locations throughout the Santa Monica campus; and the UCLA Spine Center in Santa Monica which provides comprehensive medical and surgical treatment for all spinal disorders and strives to be at the forefront of spinal research. The hospital also has an alliance with the Orthopaedic Institute for Children, formerly known as “Los Angeles Orthopaedic Hospital.

Founded in 1926 as Santa Monica’s first hospital by local physicians Drs. William S. Mortensen and August B. Hromadka, the medical center has grown and evolved over the years to better serve Santa Monica and surrounding communities. In 1942, the hospital became part of the Lutheran Hospital Society, where it remained until 1988, when it joined UniHealth America. In 1995, the hospital was acquired by the University of California and became an integral part of UCLA Health’s expanding network of medical services. It was rebuilt in phases following the 1994 Northridge earthquake and is now designed and constructed to the latest seismic standards. More than 25 percent of the medical campus is dedicated to green and open spaces, including a 40,000-square-foot garden facing 15th Street and the 18,000-square-foot Harman Garden Plaza. Both areas offer a tranquil setting where patients, visitors and staff members can enjoy fresh air, sunshine and sea breezes.

Last updated July 1, 2018

Located next to the Ronald Reagan UCLA medical center, the UCLA Medical Plaza offers an accessible, friendly environment for a broad range of outpatient services, including more than 80 specialty clinics. The plaza is composed of the following facilities:

• 100 Medical Plaza, a 140,000 square foot facility, provides space for approximately 100 physicians who are currently members or are eligible to become members of the clinical faculty of the School of Medicine. The building is owned and operated by a private firm under a long-term ground lease from the Regents of the University of California. It is the first facility of its kind to be privately developed, financed and operated on a UC campus.
• 200 Medical Plaza, a six-story, 380,000-square-foot outpatient care center, house virtually all of UCLA Medical Center’s outpatient services. It offers a complete range of services, from a Family Health Center offering primary care for routine illnesses, to clinics providing state-of-the-art outpatient treatments for complex cancers. The facilities in the Surgery Center enable patients to go home the same day following many types of surgical procedures.
• 300 Medical Plaza, a 104,000-square-foot building on the southern end of the plaza, houses outpatient and training programs of the Stewart and Lynda Resnick Neuropsychiatric Hospital at UCLA and the Jane and Terry Semel Institute for Neuroscience and Human Behavior, as well as the medical center’s rehabilitation program.

Last updated May 24, 2019

The VA Greater Los Angeles Healthcare System (VAGLAHS) is one of the largest health care facilities within the Department of Veterans Affairs. It is one component of the VA Desert Pacific Healthcare Network (VISN22) offering services to Veterans residing in Southern California and Southern Nevada. VAGLAHS consists of two ambulatory care centers, a tertiary care facility and 8 community based outpatient clinics. VAGLAHS serves Veterans residing throughout five counties: Los Angeles, Ventura, Kern, Santa Barbara, and San Luis Obispo. There are 1.4 million Veterans in the VAGLAHS service area. VAGLAHS is affiliated with both UCLA School of Medicine and USC School of Medicine, as well as more than 45 colleges, universities and vocational schools in 17 different medical, nursing, paramedical and administrative programs. The VA Greater Los Angeles Healthcare System is accredited by The Joint Commission. The VA Greater Los Angeles Healthcare System directs the Department of Veterans Affairs’ largest educational enterprise. VAGLAHS serves as a major training site for medical residencies sponsored by the UCLA David Geffen School of Medicine and USC School of Medicine, as well as more than 45 colleges, universities and vocational schools in 17 different medical, nursing, paramedical and administrative programs. Over 500 University residents, interns, and students are trained at the VA Greater Los Angeles Healthcare System each year. The institution sponsors 16 medical residencies and numerous associated health residencies and internships in dentistry, podiatry, optometry, pharmacy, clinical psychology, social work and dietetics.

Last updated July 1, 2018

The UCLA Advanced Heart Failure Program is an integrated service dedicated to providing attending-level phone consultation 24 hours a day, 7 days a week, 365 days a year. They have over the last 2 years been re-organized in the integrated Advanced Heart Failure Program with the Ahmanson-UCLA Cardiomyopathy Center, Mechanical Circulatory Support Center and Heart Transplant Center. The referring physician will speak to the attending cardiologist on-call within five minutes to facilitate the prompt and appropriate evaluation and care of the patient. The Advanced Heart Failure Program provides direct access to the team responsible for the management of all aspects of advanced heart failure, including inpatient and outpatient NYHA Class III and IV patients with heart failure. The team also accepts referrals of patients for heart transplantion and mechanical circulatory support (VAD) implantation.

Last updated July 1, 2019

UCLA has a strong record of bioinformatics research and graduate training. In 1999 the faculty established a graduate core curriculum in bioinformatics, which has been offered continuously since that time, and recently has been greatly expanded, demonstrating the faculty’s commitment to collaborative teaching and to long-term development of an integrated bioinformatics program. These initiatives have been recognized by a large number of awards of multi-investigator Project and Training grants in bioinformatics from NIH, NSF, DOE and other funding sources. The Bioinformatics IDP provides an academic home for bioinformatics at UCLA that brings together the many different disciplines that this field requires. Examples of current bioinformatics research conducted by the core faculty include: The analysis of gene and protein sequences to reveal protein evolution and alternative splicing; the development of computational approaches to study and predict protein structure to further our understanding of function; the analysis of mass spectrometry data to, for example, understand the connection between phosphorylation and cancer; the development of computational methods to utilize expression data to reverse engineer gene networks in order to more completely model cellular biology; the study of population genetics and its connection to human disease.

Last updated July 1, 2019

Graduate Programs in Bioscience is a consortium of 10 home areas and their affiliated Ph.D. programs, organized to provide the best possible research training and professional development for graduate students pursuing Ph.D.s in the life and biomedical sciences. UCLA has a long tradition of excellence and leadership in the biomedical and life sciences and in developing innovative and effective graduate training programs. In 1993, UCLA developed the ACCESS program, one of the nation’s first unified admissions and first year training programs for graduate students entering bioscience Ph.D. programs. ACCESS was a model for umbrella programs that followed at other institutions. Graduate Programs in Bioscience expands and refines the ACCESS model. Initiated in 2013 following extensive strategic planning, the programs build on the strengths of ACCESS by providing an organized network of programs that offers students breadth and flexibility to best pursue their interests across the wide range of bioscience Ph.D. programs. At the same time, programs introduce the benefits of individually tailored education in smaller training communities, defined by research themes, not traditional departments. Graduate Programs in Bioscience are invigorated and enthusiastic in our continued commitment to a program that empowers our students to excel.

Programs in the Biosciences include:

• Biochemistry, Biophysics & Structural Biology
• Bioinformatics
• Cell & Developmental Biology
• Gene Regulations, Epigenomics & Transcriptomics
• Genetics & Genomics
• Immunity, Microbes & Molecular Pathogenesis
• Molecular, Cellular & Integrative Physiology
• Molecular Pharmacology
• Neuroscience
• Physics & Biology in Medicine

Last updated July 1, 2019

The California Center for Population Research (CCPR) was established in 1998 and has since, been a leading research center for research and training in demography. CCPR is comprised of over 90 active faculty researchers from an array of academic disciplines, such as epidemiology, public policy, economics, sociology, and public welfare. CCPR researchers span several schools, including the College of Letters and Sciences, the Division of Social Sciences, the School of Public Health, the School of Medicine, and the School of Public Affairs, as well as academic departments within UCLA.

Last updated July 1, 2019

The California NanoSystems Institute (CNSI) is a hub of interdisciplinary research, translation, and education where scientists from diverse fields find common purpose in addressing grand challenges of the 21st century. With locations at the University of California’s Los Angeles and Santa Barbara campuses, the CNSI leverages public and private investment to drive collaborative nanoscience research across disciplines, translates discoveries into knowledge-driven commercial enterprises, and educates the next generation of scientists and engineers. Through an integrated framework of core platforms, the CNSI at UCLA provides leading-edge R&D infrastructure and professional services to provide a competitive edge for UC-affiliated researchers and startups in the discovery, development, and application of transformative technologies. Facilities include the following technology centers: Advanced Light Microscopy and Spectroscopy (ALMS) Lab, Electron Imaging Center for Nanomachines (EICN), Integrated Nanomaterials Laboratory (INML), Integrated Systems Nanofabrication Cleanroom (ISNC), Molecular Screening Shared Resource (MSSR), Nano and Pico Characterization Laboratory (NPC), and CNSI Laboratory Management System.

Last updated July 1, 2019

The USC/UCLA Center on Biodemography and Population Health (CBPH) is a multisite center located at the Andrus Gerontology Center of the University of Southern California and the Program in Geriatric Medicine in the School of Medicine of the University of California at Los Angeles. It is one of 14 centers in the Demography and Economics of Aging Centers Program sponsored by the National Institute on Aging (NIA). The primary purpose of the CBPH is to provide a synergistic research environment for the integration and translation of research findings from a variety of disciplines to understand population health. The Center takes a multidisciplinary approach by linking demographers, biologists, economists, psychologists, epidemiologists, health policy specialists, medical researchers and clinical geriatricians. This integration of biological, epidemiologic and medical risk information which characterizes Center research is fundamental to understanding and projecting demographic trends and differences in population health.

Last updated July 1, 2019

The Center for Cancer Prevention and Control Research is a joint program of the School of Public Health and the Jonsson Comprehensive Cancer Center at UCLA. Since its inception in 1976, the Center has been nationally and internationally recognized for its pioneering work in cancer prevention and control research. NCI-designated Cancer Centers are a major source of discovery of the nature of cancer and of the development of more effective approaches to cancer prevention, diagnosis and therapy. They also deliver medical advances to patients and their families, educate health-care professionals and the public and reach out to underserved populations. They are characterized by: strong organizational capabilities; institutional commitment; trans-disciplinary, cancer-focused science; experienced scientific and administrative leadership and state-of-the-art cancer research and patient care facilities.

The Center conducts rigorous peer-reviewed research in three major areas: The Healthy and At-Risk Populations Program, The Patients and Survivors Program, and The Molecular Epidemiology Program.

Last updated July 1, 2019

Duchenne Muscular Dystrophy is one of the most common and devastating genetic diseases of childhood, affecting approximately 1 in 5000 boys. Progressive muscle degeneration leads to loss of ambulation by age 12, loss of upper arm use in the teen years, and heart and respiratory failure leading to death in the 20's. The Center for Duchenne Muscular Dystrophy at UCLA leads the nation in translational science focused on Duchenne and is the first comprehensive Duchenne clinic in the western United states. A leading group of UCLA scientists, clinicians and researchers is poised to achieve significant advances in research, clinical care and treatments for Duchenne that are improving, and will potentially extend, the lives of those afflicted. Established in 2006, the CDMD at UCLA was built as a result of collaborations among UCLA scientists, clinicians and researchers. Its efforts span from education and outreach to cutting- edge research, drug discovery, clinical trials and care. Funding for the CDMD's remarkable achievements to date has come from a combination of research grants and private philanthropy. The goals of the CDMD are to identify additional disease modifying drug targets; perform intelligent drug design; improve access and care in the clinical setting; and increase clinical trial participation.

Last updated July 1, 2019

The Center for Healthier Children, Families & Communities is a multidisciplinary, community-focused research, policy, and training center at UCLA. Established in 1996, the Center is a joint effort of the David Geffen School of Medicine Department of Pediatrics and the UCLA Fielding School of Public Health. The Center also includes faculty from the UCLA Luskin School of Public Policy & Social Research, School of Law, and the College of Letters and Sciences. Integrating expertise across disciplines ensures that the solutions we develop are theoretically sound and highly practical. We also partner with leading organizations across the country to create and spread forward-thinking ideas and strategies.

Many of the diseases that threaten the health of the entire population begin in childhood. By understanding how health develops across the span of an individual’s life, the Center’s projects point toward inventive solutions to urgent health problems. The Center’s unique method unites pediatricians, public health experts, psychologists, economists, lawyers, and policy experts with local families, communities, and businesses to develop novel and responsive programs to improve children’s health; increase the efficiency, effectiveness, and distribution of health and social services; assist communities in transforming into healthier environments; and turn data into information that can be used to make decisions and implement action.

Last updated July 1, 2019

The UCLA Children’s Discovery and Innovation Institute (CDI) was founded in 2012 to inspire scientific discovery and design new avenues for innovation, to cultivate collaborative teams and research support systems, and to ensure its pediatric physician scientists can improve the lives of children today and in the future. To connect all research and training activities related to improving children's health and health care, spanning from discoveries in basic science, through translation to clinical care, and moving towards implementation in community practice through collaborations and networks established locally, nationally and globally. Among some significant figures, the CDI has: 76 internally funded grants for a total $6.9 million and includes co-partnered grants with UCLA CTSI, generated $9 million in new externally-funded grants, a total $36 million in awards and roughly 200 external grant proposals submittted annually, 105 active faculty researchers, 42 research coordinators, 14 central grant administrative staff, annual symposiums and a seminar series.

Last updated July 1, 2018

The Collaboratory, a central component of the Institute for Quantitative & Computational Biosciences (QCB), provides the experimental and empirical research environment where bioscientists and computational scientists work together to design and conduct experiments to improve our understanding of biological systems. As large-scale data analysis is often limited to most bioscience laboratories, the Collaboratory’s main mission is to facilitate genomic data analysis by bringing together UCLA bioscience faculty with a select group of QCB post-doctoral fellows dedicated to the Collaboratory. Individual post-doctoral fellows are assigned to work on specific bioscience research projects to develop and implement tailored methodologies for genomic analysis. In addition, the fellows are responsible for organizing intensive tutorials to train UCLA students and postdocs in the latest next-generation sequence analysis techniques. The Collaboratory has also set up and maintains a next-generation sequence data analysis server.

Last updated July 1, 2018

The Crump Institute for Molecular Imaging brings together faculty, students, and staff with a variety of backgrounds - physics, mathematics, engineering, biology, chemistry, and medicine - to pursue innovative technologies and science to accelerate our understanding of biology and medicine. Innovative technology programs, linked by systems biology, microfluidics, nanotechnology, and molecular imaging, provide the tools to conduct integrated science in a unique, interdisciplinary setting.

With an initial focus on cancer and immunity, our goal is to develop new technologies to observe, measure, and understand biology in cells, tissues, and living organisms. Through molecular imaging - taking pictures of the living chemistry of cells and tissues of the body, we can watch biology in action in living organisms. The Crump Institute's ultimate objective is to provide medicine with new science and technologies to judge the state of health, and identify the early transitions to disease for the development and use of new therapies as part of the new era in molecular medicine.

Last updated July 1, 2018

The Center for Cancer Prevention and Control Research is a joint program of the School of Public Health and the Jonsson Comprehensive Cancer Center at UCLA. Since its inception in 1976, the Center has been nationally and internationally recognized for its pioneering work in cancer prevention and control research. NCI-designated Cancer Centers are a major source of discovery of the nature of cancer and of the development of more effective approaches to cancer prevention, diagnosis and therapy. They also deliver medical advances to patients and their families, educate health-care professionals and the public and reach out to underserved populations. They are characterized by: strong organizational capabilities; institutional commitment; trans-disciplinary, cancer-focused science; experienced scientific and administrative leadership and state-of-the-art cancer research and patient care facilities. The Center conducts rigorous peer-reviewed research in three major areas: the Healthy and At-Risk Populations Program focuses on the prevention and early detection aspects of the cancer control continuum; the Patients and Survivors Program has as its major goal the reduction in avoidable morbidity and mortality among patients with cancer, long-term survivors of cancer; the Molecular Epidemiology Program focuses on: (1) Primary prevention: examining environmental exposure (smoking, diet, infection, air pollution, etc.) and genetic susceptibility and cancer risk, as well as exploring gene-environmental interactions in cancer risk; (2) Secondary prevention: evaluating biological markers (somatic mutations and hyper-methylations of tumor suppressor genes and oncogenes, gene copy numbers, etc.) for early detection, as well as intermediate markers as surrogate end-points for chemoprevention; and (3) Tertiary prevention: assessing blood and tissue-based biological markers (tumor markers, SNPs, etc.) for cancer prognosis and survival prediction.

Last updated July 1, 2018

The Division of Laboratory Animal Medicine (DLAM) comprises 166,741 sq. ft. of animal facilities. The department is staffed by four full-time veterinarians, eleven veterinary technicians and research associates, 92 animal technicians (including their supervisors) and 19 support staff (clinical and diagnostic labs; administrative personnel and training personnel). All veterinary and technical staff are located on site and available at all times. Animal technicians and veterinary technicians monitor animal health daily including weekends and holidays. Veterinarians examine animals that are reported as sick or injured and conduct routine facility rounds at least weekly. If animals exhibit any indications of illness, injury or distress, veterinary staff confers with research personnel to recommend and agree on appropriate treatment or euthanasia.

Animals are housed in UCLA IACUC-approved animal facilities under temperature and ventilation controlled conditions. Facility staff ensure animals receive fresh food, water and clean bedding on a regular basis (weekly, bi-weekly or more often). Animal care staff carry out routine husbandry procedures including changing cages, feeding and watering. Animals are checked daily by animal care staff to assess their health condition. Animal care and veterinary attention is available 24/7, 365 days a year on an on-duty or on-call basis.

Three dedicated facilities are available for the breeding and maintenance of mice. Dedicated technical personnel with expertise in breeding colony management are available to provide breeding services and consultation.

Last updated September 23, 2020

Life Sciences has nine academic departments: Ecology and Evolutionary Biology; Integrative Biology and Physiology; Microbiology, Immunology, and Molecular Genetics; Molecular, Cell, and Developmental Biology; Psychology; Society and Genetics; Department of Life Sciences; Computational & Systems Biology IDP; and Neuroscience IDP. The faculty are nationally and internationally recognized for their contributions to science and education. Their research is broadening the understanding of how living systems work– to improve mental health, physical health, the health of our planet; and to find biological solutions to meet our growing demands for food and fuel. The students are among the best in the country, and the division is committed to the best education and training possible, to prepare students for their future careers.

Last updated July 1, 2018

The UCLA Graduate School of Education & Information Studies does fundamental work on what matters most in education and information studies in the 21st Century: the discovery and application of usable knowledge at the crossroads of policy and practice.

The program is home to sixteen nationally renowned research centers, three groundbreaking partnership schools, and some of the world’s premiere education and information experts. This is where the most pressing issues in education and information are transformed by UCLA and strategic partners into opportunity and real-world solutions.

Last updated July 1, 2018

UCLA Samueli is a tightly knit community of 180 full time faculty members, 3,500 undergraduate and 3,000 graduate students, and 40,000 active alumni. Known as the Birthplace of the Internet, UCLA Samueli is also where countless other fields took some of their first steps – from artificial intelligence to reverse osmosis, from mobile communications to human prosthetics. Counted among its luminaries are 38 current members of the National Academy of Engineering, three Turing award winners, one national Medal of Science recipient and one Nobel Prize laureate. Samueli leads multinational aerospace companies, builds skyscrapers and founded $18 billion tech ventures. Samueli row in the Olympics, build robots that compete in international soccer matches and win Academy Awards.

Samueli is consistently ranked in the Top 10 among U.S. public engineering schools. It’s online master’s program ranks in the Top 3. What sets UCLA Samueli apart from other engineering schools is its sense of community – fostered on campus and carried on through alumni relationships over the ensuing decades.

Last updated July 1, 2018

he ICNN provides advanced analysis and informatics support to a highly interactive user group consisting of neuroscientists at UCLA, who are conducting basic, clinical, and translational research. These investigators have access to excellent facilities for genetics and genomics experimentation; the lack of corresponding resources in analysis and informatics constitutes a bottleneck in their research. ICNN faculty experts in statistical genetics, gene expression analysis, and bioinformatics will oversee the activities of highly-trained staff members who will accomplish three goals: providing expert consultation and analyses for neurogenetics and neurogenomics projects; developing and maintaining a shared computing resource that will include a computational cluster for computation-intensive analyses, web-servers and state of the art software tools for a wide range of applications (including user-friendly versions of public databases, as well as workstations on which ICNN users will be trained to employ these tools; providing hands-on training in analysis and informatics to the users. ICNN is developing a whole-genome data analysis pipeline, aimed at filtering and prioritizing genetic variation identified in whole-genome sequencing studies for further study.

Last updated July 1, 2018

The Institute for Digital Research and Education (IDRE) is a cooperative of faculty and technologists working to advance the existing body of computing knowledge and expertise at UCLA. The IDRE mission is to support, advance and guide a campus-wide program to position UCLA as a world leader in research and education in computational thinking, using high performance computation, data visualization and data analysis of large data sets and databases. IDRE supports research and innovative scholarship that takes advantage of new technologies and encourages collaboration between faculty from different departments and disciplines at UCLA, the opening of new research questions, and the enrichment of the learning environment. The goal of this campus-wide collective is to make UCLA a world leader in high-performance computing and visualization research and education.

IDRE programs are focused on the challenges and opportunities associated with five areas critical to advancing innovative research and scholarship: Computation and Storage, GPU/Many Core, Pipeline to Leadership Class Facilities; Statistical Computing/Data Informatics; and GIS, Visualization and Modeling. Through the IDRE Research Technology Group (RTG), IDRE provides services and support aligned with the five program areas. IDRE’s unique computational capability includes High Performance Computing resources and expertise, Grid and Cloud Access Services, Cluster Services, the Grid Portal, and UCLA’s data center system.

Last updated July 1, 2018

For more than 55 years, UCLA Fielding School of Public Health has played an instrumental role in advancing the field of public health in the areas of research, training and service. Our world class faculty in collaboration with students have made research discoveries that have improved the health of communities large and small around the world; our talented students come from all over the globe to receive training and mentoring from our faculty, then take their knowledge to become leaders in communities as far as the Congo and as near as East LA; through our field study programs, faculty and students bring information and education to underserved communities, that have changed behaviors and saved lives. Quick Facts include: 595 (384 masters and 211 doctoral) students from 31 nations, 250 faculty (61 full-time), a total budget of $68 million, and 10,893 alumni. Departments include: Biostatistics, Community Health Sciences, Environmental Health Sciences, Epidemiology, and Health Policy and Management.

Last updated July 1, 2018

With a membership of more than 500 physicians and scientists, UCLA's Jonsson Comprehensive Cancer Center (JCCC) is one of the largest comprehensive cancer centers in the nation. JCCC handles more than 20,000 patient visits per year and conduct hundreds of clinical trials, providing the latest in experimental cancer treatments. JCCC has established an international reputation for providing the best in experimental and traditional cancer treatments and expertly guiding the next generation of medical researchers. JCCC currently operates eight research programs organized to foster excellence in interdisciplinary and collaborative research across academic units. Those programs are: cancer and stem cell biology, cancer molecular imaging, cancer nanotechnology, gene regulation, healthy and at-risk populations, patients and survivors, signal transduction and therapeutics and tumor immunology. Each program provides a platform for colleagues with similar scientific interests, allowing them to exchange information and ideas, facilitate and promote their research interactions and provide access to shared resources.

Last updated July 1, 2018

Established in 1966, the UCLA Stein Eye Institute vision-science campus is the fulfillment of an ambitious plan by ophthalmologist, businessman, and philanthropist Jules Stein, MD, and Bradley R. Straatsma, MD, JD, founding director of the Stein Eye Institute and founding chairman of the UCLA Department of Ophthalmology, who created a bold plan for preventing blindness through comprehensive programs for patient care, vision-science research, education and training of the next generation of physicians, and eye health outreach both local and global. Under the leadership of Bartly J. Mondino, MD, director and chairman since 1994, a broad agenda of program building and expansion has been implemented: the first Stein Eye Center opened in Santa Monica in 2012; the UCLA Department of Ophthalmology created the nation’s preeminent organization for ophthalmic care and vision research by forging a historic affiliation with the Doheny Eye Institute in 2013; and the Edie & Lew Wasserman Building, a landmark research and patient-care facility with a state-of-the-art outpatient surgical center, opened in 2014. Combined, UCLA Stein Eye Institute, Stein Eye Center, Doheny Eye Center UCLA, and UCLA-affilliated hospitals provide patients across the Southland with access to the finest vision care.

Last updated July 1, 2018

The Specialty Training and Advanced Research (STAR) Program at the David Geffen School of Medicine at UCLA is a unique curriculum designed for optimal training of physician-scientists. Started in 1993, this program offers the opportunity to combine clinical fellowship or residency training with formal, advanced research training leading to a graduate degree, coordinated with clinical training. Fellows/residents admitted to the STAR Program complete clinical training toward board certification in internal medicine, its subspecialties (including cardiology, digestive diseases, hematology/oncology, dermatology, endocrinology, pulmonary and critical care, rheumatology, infectious diseases, nephrology, and clinical immunology and allergy) or in other departments, including neurology, pathology, pediatrics, psychiatry or one of the surgical disciplines (including Surgery, Obstetrics/Gynecology, or Ophthalmology). In general, the STAR Program begins with approximately 12-24 months of clinical training, followed by research training in one of four research career tracks: basic Science, clinical research, health services/outcomes, clinical research, and postdoctoral research training. Additional specialty clinical training may be integrated into the research years. The research portion is usually 2-4 years. STAR Awardees receive salary support and benefits from their clinical department commensurate with clinical training (PGY) level, as well as graduate school tuition throughout the clinical and graduate research years.

STAR graduates' successes include: 80% of graduates have continued in research positions either within academia (72%) or industry (8%), 49% have obtained an NIH K or other type of career development award, 19% have received an NIH R01 or equivalent grant, several graduates hold leadership positions, including Department Chair/Vice Chair, Assistant Vice Chancellor for Research, Division Chief, Executive Medical Director, Vice President for a health benefits company, Chief Medical Officer for a pharmaceutical firm, and Chief Scientific Officer of a university-affiliated research institute, and more than 130 have graduated in the first 20 years and received an NIH R01 or equivalent grant.

Last updated July 1, 2018

UCLA Anderson offers both degree and non-degree programs to meet the diverse educational needs and professional goals of students. UCLA Anderson's rigorous programs offer exceptional academic preparation, a cooperative and congenial student culture, and access to a thriving business community, as well as support services for scholastic and career advancement. Specialized centers support faculty research and sponsor courses, extracurricular activities and conferences. They also provide varied opportunities for continuing education and interaction between scholars, students and industry leaders. Anderson has a global network of more than 39,000 alumni, 720 students and 150 faculty members.

Last updated July 1, 2018

The Business of Science Center (BSC) is a multi-disciplinary group of students and professionals committed to developing university discoveries into problem-solving commercial products. Whether you are a student looking for an introduction to business, a faculty inventor searching for an industry partner, or an industry professional looking for “the next big thing,” you will find it with the BSC. BSC encourages innovation and entrepreneurship at UCLA in order to bring academic discoveries to the public domain. BSC supports faculty inventors in all stages of commercialization. Through their programs and courses, they give students hands-on experience in market and intellectual property research, business plan development, effective communication strategies for securing funding from venture capital, and more. Industry professionals act as mentors to both faculty and students in growing discoveries into products that can improve the lives of many.

Last updated July 1, 2018

The UCLA Center for Health Advancement (The Center) provides enhanced analysis and evidence based information to help policy makers decide which policies and programs can best improve health and reduce health disparities. The Center analyzes a wide range of timely health improvement opportunities, identifying those supported by strong evidence. It presents and disseminates the results of these analyses in plain language to those who make and influence public and private sector policies and programs. The Center also provides training and technical assistance to facilitate implementation of recommended approaches. The Center brings together faculty from multiple Departments of the Fielding School of Public Health and other UCLA Schools with a wide range of subject matter and methodological expertise, including expertise in non-health sectors, such as education, transportation, housing, environmental protection, community planning, agriculture, public welfare, and economics. It has strong collaborations with governmental public health agencies, foundations, academic institutions and other not-for-profit organizations. Within the health sector, its work is focused on how alternative investments to wasteful expenditures in health care can yield greater returns.The Center has core expertise in health impact assessment, health forecasting, and modeling inter-sectoral planning and analysis. Its research collaborations enable an enhanced, broadened understanding of how to improve the public's health and health equity effectively and efficiently. Topics for analysis are selected based on an understanding that the major determinants of our collective health and health disparities are the social, economic and physical environments.

Last updated July 1, 2018

The UCLA Center for Health Policy Research (CHPR) is one of the nation's leading health policy research centers and the premier source of health policy information for California. The Center is the home of the California Health Interview Survey (CHIS) and is affiliated with the UCLA Fielding School of Public Health. The Center conducts research on a variety of national, state and local health policy issues, including health insurance, health care reform, health economics, health disparities and chronic disease. The Center is a collaboration of dozens of leading health and health policy researchers from UCLA and beyond. Under the guidance of Gerald Kominski, PhD, as well as an executive leadership committee, the Center is able to draw on diverse backgrounds in public health, medicine, law, economics and social science to advance our understanding of health and health policy. CHPR conducts research on a variety of national, state and local health policy issues, including: economics of health care, health insurance coverage, access to, and quality of, care, prevention of chronic illness, racial and social disparities in health care access and health status, children’s health, women’s health, senior health, American Indian/Alaska Native health, enhancing the health of communities, survey methodology, survey statistics, and small area estimation. CHPR also provides topic-specific exercise through the following programs: the California Health Interview Survey (CHIS), Health DATA, Health Economics & Evaluation Research (HEER) Program, and the Health Insurance Program.

Last updated July 1, 2018

The Center strengthens resiliency and mental health in partnership with communities. The Center houses UCLA clinical faculty that includes adult psychiatrists and psychologists, child and geriatric psychiatry specialists, and staff, including doctoral level social scientists, master's level statisticians, and research and administrative staff. Our mission is to strengthen resiliency and improve the mental health of local and national diverse populations through rigorous research, effective programs, and partnering with consumers, children and their families, community-based and policy agencies.

Our values include: Community—collaborating with diverse partnerships to create an environment that promotes healthy development and well-being across the lifespan, Compassion—promoting respect, understanding and dignity towards persons and their families living in under-resourced communities, Creativity—using media, technology, and the arts to address stigma and engage populations, Communication—leveraging advances in mobile health technologies to improve access, engagement, and empowerment in mental health care, Commitment—dedicating effort and resources to engaging communities in all phases of research, from design to dissemination and Knowledge—employing rigorous partnered-research to promote a culture of health equity through two-way knowledge exchange and policy reform.

Last updated July 1, 2018

Utilizing our expertise in Pediatrics, Human Genetics, and Pathology, the UCLA Clinical Genomics Center provides a comprehensive analysis and diagnostic interpretation of a patient's entire protein-encoding genome by searching through 37 million base pairs in 20,000 genes to potentially locate the single DNA change responsible for the patient's disorder. Rather than analyzing genes one-by-one, this universal diagnostic service simultaneously investigates all possible causative genes in a time- and cost-effective manner and includes certified genetic counselors for pre- and post-test counseling as well as consultation from specialist physicians. This service utilizes next generation sequencing technology, state-of-the-art computational and bioinformatic resources, and integrated laboratory information systems to deliver a precise genetic diagnosis for the benefit of patients and physicians. Services include: clinical exome sequencing, integrated bioinformatics and data storage, expert interpretation by our Genomic Data Board, and fast report turnaround time.

Last updated July 1, 2018

The David Geffen School of Medicine at UCLA (DGSOM) is one of the top ranked medical schools in the United States. Since opening in 1951, DGSOM has grown into an internationally recognized leader in research, medical education, patient care, and public service. DGSOM has had over 5,500 research proposals funded and engages the efforts of more than 2,500 full-time faculty in its 18 departments, many of whom have been recognized with national and international awards and honor. The medical school was ranked 4th in the United States in research funding from the NIH in FY2020. DGSOM receives more than $677M annually in research funding; from a 2020 report, the School of Medicine alone accounted for approximately $590M of the campus’ overall NIH research funding, contributing to a total of more than $1 billion annually in research awards at UCLA. The School of Medicine’s education and training currently encompasses more than 1,000 residents and fellows, over 750 medical students, over 450 postdoctoral fellows, and nearly 500 graduate students working toward PhD degrees in health-related sciences, with access to 438 active training and career development awards. There are now nearly 200 endowed chairs. The school focuses on six overarching goals: ensuring that academic medicine continues to thrive at UCLA, fostering interdisciplinary efforts, increasing the financial transparency of the school, transforming the culture of the school to ensure all individuals are welcome and valued, enhancing mentorship and leadership training programs, and elevating the school’s internal and external communications. UCLA’s medical school ranks No. 13 in primary care and continues to be highly ranked in U.S. News & World Report's 2023 Best Medical Schools. 

Last updated April 6, 2022

The UCLA Department of Human Genetics is the youngest basic science department in the Geffen School of Medicine at UCLA. When the Department was launched just prior to the sequencing of the human genome, it was clear that the practice of genetics research would be forever changed by the infusion of massive amounts of new data. Organizing and making sense of this genomic data is one of the greatest scientific challenges ever faced by mankind. The knowledge generated will ultimately transform medicine through patient-specific treatments and prevention strategies. The Department is dedicated to turning the mountains of raw genetic data into a detailed understanding of the molecular pathogenesis of human disease. The key to such understanding is the realization that genes not only code for specific proteins, but they also control the temporal development and maturation of every living organism through a complex web of interactions. The department serves as a focal point for genetics research on the UCLA campus, with state of the art facilities for gene expression, sequencing, genotyping, and bioinformatics. In addition to its research mission, the Department offers many exciting training opportunities for graduate students, postdoctoral fellows, and medical residents.

Last updated July 1, 2018

For more than 60 years, the Department of Medicine at UCLA has engaged in world-class medical research, teaching, and patient care. Across 14 sub-specialties, our physicians are world-renowned experts in the prevention, diagnosis, and treatment of complex and routine illnesses. UCLA investigators are situated within the following divisions and centers: Cardiology, CARE Center, Center for East-West Medicine Clinical Immunology and Allergy, Clinical Nutrition, Dermatology, Digestive Diseases / Gastroenterology, Endocrinology, General Internal Medicine, Geriatric Medicine, Hematology Oncology, Infectious Diseases, Nano Medicine, Nephrology, Pulmonology / Pulmonary and Rheumatology.

Last updated July 1, 2018

The primary objective of DOMStat is to provide state-of-the-art study design and statistical analysis collaboration to investigators in the Department of Medicine. DOMStat offers faculty and staff level statistical collaboration for grant proposals, data analysis, manuscript preparation, and other research activities requiring statistical input. Investigators are encouraged to schedule an initial meeting early in their research to allow DOMStats to best assist with the study design, statistical analysis plans, data collection plans, database design, and interpretation of research results.

Last updated July 1, 2018

The Department of Neurology at UCLA was founded by Augustus S. Rose, MD, in the 1950s in the UCLA School of Medicine. The department grew from a few faculty members in that era to more than 100 in present times. The department is also the home to 125 trainees and is associated with seven affiliated hospitals. The faculty of the Department of Neurology are distinguished scientists and clinicians who have been ranked #1 or #2 in NIH funding since 2002. New and renovated laboratory space typifies the efficient, effective and handsome surroundings in which the department is situated. The Department of Neurology is divided into disease-specific and method-specific programs including all of the major categories of neurological diseases and methods that include neurogenetics and neuroimaging as well as health services research. 

The Neurology Residency Training Program in the Department of Neurology at UCLA began in the 1960s, at a time when the department moved to the Reed Neurological Research Center. The Department of Neurology is also the founding division of the Neuropsychiatric Institute, recently renamed the Jane and Terry Semel Institute for Neuroscience and Human Behavior. Many faculty also belong to the UCLA Brain Research Institute. The department and its faculty, trainees and staff are part of a larger UCLA neuroscience community. On the UCLA campus, more than 250 faculty are neuroscientists—making this discipline the largest single entity on the entire campus. This has resulted in a tremendous building program with many laboratory buildings committed to neurogenetics, cellular and systems neuroscience.

Last updated October 16, 2020

As an investigative discipline, pathology researchers identify the origins of disease and contribute to strategies for its treatment. As a medical discipline, pathologists engage in patient care as consultants and innovators for biochemical, molecular, and cell biology tests that guide diagnostic and treatment choices. Through these roles, the Department of Pathology and Laboratory Medicine at UCLA assists doctors and patients in making optimal decisions based on the latest diagnostic studies, using state-of-the-art instrumentation. Each month, approximately 50,000 clinical tests, and 1,500 biopsy and cytology cases, are analyzed to guide the care of patients in UCLA Health System, and through our referral network regionally and nationally.

Last updated July 1, 2018

The Division of General Internal Medicine and Health Services Research at UCLA has well over 200 faculty members associated with the Division, including large numbers of ambulatory and hospitalist clinician-educators. The Division includes three economists, a social psychologist, multiple faculty with MDs as well as PhDs. UCLA General Internists provide long-term, comprehensive care and manage both common and complex diseases. Our faculty serves as primary care providers, providing care in neighborhood offices in the North Valley, Santa Monica, the South Bay, and Westwood, as well as the Veterans Affairs Greater Los Angeles Healthcare System.

Last updated July 1, 2018

The Early Academic Outreach Program (EAOP) is an academic preparation program established in 1976 by the University of California to expand postsecondary education opportunities for California's educationally disadvantaged students. UCLA EAOP works with students to help them become competitively eligible applicants for college admission, going beyond minimum eligibility. EAOP works collaboratively with families, educators, schools, communities, and various campus departments to provide pre-college students with challenging academic enrichment activities to promote and cultivate a college-going culture. EAOP is one of the state's most successful pre-collegiate student academic development programs. UCLA EAOP works with over 15,000 students in middle school and high school each year. This includes working with over 80 schools in 10 school districts. Since 1991, approximately 60% of EAOP seniors meet UC eligibility each year, 82% attend a postsecondary institution upon high school graduation, and 62% attend a 4-year institution, with 25% attending a UC school.

Last updated July 1, 2018

The UCLA Health Care Institute, housed in the Price Center, builds leadership and management capacity in organizations serving early childhood needs. The institute uses an innovative management based approach to prevent disease, promote health and empower underserved families and children in the United States. HCI has a portfolio of low literacy health education topics that are culturally sensitive and includes: sick day management & injury prevention, oral health promotion, diabetes and obesity prevention, and mental health and wellness. HCI provides a structured set of tools and processes for strategic implementation of health promotion, and incorporates various learning formats: in-person education sessions, reading materials and toolkits, webinars and parent trainings. Organization teams also participate as if they were parents in a mock parent-training session that allows teams to experience firsthand what parents would experience during a parent training session. Since 2001, the HCI has trained over 120,000 families in 10 languages and in 50 states. Its training methodology is used by over 300 Head Start grantees and has consistently delivered measurable outcomes in improving knowledge, changing behavior, and reducing unnecessary utilization of health care services. As a result, HCI can: increase school attendance, increase parent’s work attendance, increase staff, parent, and community engagement, improve the health literacy of staff and families, and strengthen community partnerships.

Last updated July 1, 2018

The Institute of Technology Advancement (ITA) is an off-campus technology development center established by the UCLA Henry Samueli School of Engineering and Applied Science to accelerate the transition of high-impact innovative research from UCLA to technology development and commercialization. Start-up funding for the institute was donated by the Henry and Susan Samueli and the Easton Foundation. ITA provides operational flexibility for university researchers, industry, government, and investment partners alike. The flexible organizational structure of ITA complements existing capabilities of the university and industry, allowing the center to movie quickly to promote the transition of discoveries to development and commercialization. ITA Supports Three Types of Research Activities: transitional research, developmental research, and near-term R&D support to industry. ITA, as an organization and through its business-savvy Technology Strategists, is a conduit to local, state, government agencies, industry, and venture capital investors. Each Technology Strategist has a specialized domain of expertise and relationships with various funding resources.

Last updated July 1, 2018

Founded in 1994, UCLA Luskin incorporates the best practices in scholarship, research, and teaching in the fields of social work, urban and regional planning, and policymaking. The unique intersection of these disciplines within one school allows for academic cross-collaboration and a graduate education that values diverse perspectives at the macro- and micro- organizational levels. Graduates of the master’s and doctoral programs are well prepared to take leadership roles and effect change as practitioners, researchers, and policymakers in the public, private, and non-governmental sectors.

Faculty of the Luskin School of Public Affairs are actively engaged in research that address pressing national and regional issues including immigration, drug policy, prison reform, health care financing, transportation and the environment, national security, economic development, and an aging U.S. and world population. The School is named after Meyer and Renee Luskin—UCLA alumni, Angelenos, and philanthropists—who generously gave a $100 million gift to UCLA, half of which funded endowments in the School of Public Affairs. On March 18, 2011, the School was officially named the UCLA Meyer and Renee Luskin School of Public Affairs. As of fall 2016, the school had over 7,000 alumni. 567 students were enrolled as of fall 2015.

Last updated July 1, 2018

The UCLA PRIME program is a five-year concurrent/dual degree program leading to an MD and a Masters in areas that complement the mission of the program. These might include MBA, MPH or MPP. Cohorts are composed of approximately 18 students. Students identify with one of two programs: PRIME-LA Westwood (14) or PRIME-LA CDU (4). A commitment to serve in, and experience working with, diverse medically disadvantaged populations is paramount. While programs coordinate with each other acceptance is to PRIME-LA. Applicants offered secondary applications identify their preferences as to which PRIME-LA program is of interest, PRIME-LA Westwood or PRIME-LA CDU.

Last updated July 1, 2018

The NHLBI Proteomics Center at UCLA consists of an international effort led by Dr. Peipei Ping. The central scientific goal aims to provide fundamental information on the proteome biology of cardiovascular diseases, an essential component for the Human Proteome Project. This collaborative effort has been encouraged by the UCLA leadership to advance our scientific and education missions via international collaborations. Our Center thrives to support creative investigations in proteomics science and to provide a training environment for young investigators from UCLA and from the scientific community at large.

Last updated July 1, 2018

The primary intent of the UCLA Orphan Disease Testing Center (ODTC) is to provide validated confirmation of variants identified in research laboratories which can then be reported directly to clinicians and patients who request such information for clinical decision-making. ODTC will confirm the variant in a blood or genomic DNA sample from the proband or other family members. If the variant status is unknown, a separate positive control sample is required. After a variant is confirmed, diagnostic, prenatal, and carrier testing will be available for other at-risk family members.

Last updated July 1, 2018

Two previous research laboratories, the Clinical and Translational Research Laboratory (CTRL) and the Clinical Immunology Research Laboratory (CIRL) have been restructured into the Pathology Research Portal (PRP). The PRP is a CAP accredited laboratory. This new addition to the Center for Pathology Research Services (CPRS) functions as the biospecimen liaison between researchers and clinical testing, and provides coordination for sample receiving, accessioning, processing, short term and long term storage, dispatching to multiple core facilities for testing, and result retrieving. PRP also provides shipping and temporary storage services, and can also provide customized services to meet various research needs.

Last updated July 1, 2018

The UCLA School of Dentistry was established in 1964 in response to the need for a public school of dentistry in the greater Los Angeles area. The mission of the UCLA School of Dentistry is to improve the oral and systemic health of the people of California, the nation, and the world through education, research, patient care, and public service. The highest achieving applicants, from a variety of backgrounds, are consistently admitted into UCLA Dentistry's academic programs to learn from their renowned faculty. Nearly 4,400 DDS degrees have been awarded. They receive approximately 1,900 applications every year for the 88 available slots for the incoming 4-year DDS program and more than 700 applications for the 20 available slots for the 2-year Professional Program for International Dentists program. The residency programs are among of the best and most competitive in the world. UCLA Dentistry offers 15 specialty and general dentistry programs and have more than 100 active residents at any given time.

Patients receive quality dental services, prescribed under comprehensive treatment plans and options of care. In the 2012-2013 fiscal year, nearly 142,000 patient visits were conducted by our dental students and faculty, throughout 30 different clinics. The research Centers of Excellence are focused on cancer, bone biology, bioengineering and biotechnology, molecular microbiology, neuromuscular problems and public health. In the 2012-2013 fiscal year, grants to faculty from the National Institutes for Health and other funding agencies reached $16 million. As part of the curriculum, students are required and given numerous opportunities to interact with the population at large in order to experience first-hand the oral health challenges and needs associated with groups in the community. In the 2012-2013 fiscal year, our dental students, residents and faculty administered free dental care and oral hygiene instructions to more than 2,000 community members at various health fairs and clinical care sites throughout the Southern California region.

Last updated July 1, 2018

Founded in 1949, UCLA School of Law has garnered a reputation for artful teaching, influential scholarship and enduring innovation. As the first public law school in Southern California and the youngest top-ranked law school in the United States, UCLA Law has consistently pushed new boundaries in the study and practice of law. Over the decades, UCLA Law has developed a depth and breadth of academic offerings unsurpassed by any other law school in the nation. The Epstein Program in Public Interest Law and Policy is among the best anywhere. UCLA Law is one of four among the top 20 law schools with a specialization in Business Law and Policy–and the only one to offer a specialization in Critical Race Studies. UCLA Law’s faculty also has emerged as one of the most influential nationwide. Our professors are leading scholars in areas including bankruptcy, corporate law, constitutional law, critical race theory, entertainment law, environmental law, intellectual property and tax law.

Today, the UCLA Law alumni community is more than 15,000 strong and extends around the world. Alumni live and practice in virtually every state, the District of Columbia, multiple U.S. territories and more than 50 foreign nations. These graduates excel in their chosen fields, from private practice to business to government to public interest and beyond. UCLA Law has a long tradition of distinction on the bench, with more than 320 alumni who are serving, or have served, on courts throughout the country. Six UCLA Law alumni are now judges on the U.S. Court of Appeals for the Ninth Circuit–the largest number of graduates from any one law school who are serving on the court.

Last updated July 1, 2018

The UCLA School of Nursing prepares nurses and scholars to lead and transform nursing care in a rapidly changing, diverse and complex healthcare environment through academic excellence, innovative research, superior clinical practice, strong community partnerships, and global initiatives. The UCLA School of Nursing is ranked as one of the top nursing schools in the country by US News and World Reports. Through its innovative curriculum, students learn relevant theory, acquire practice skills and are socialized into the profession of nursing. The School of Nursing provides rich opportunities for students to pursue collaborative and interdisciplinary education and independent study projects. Individual academic counseling a variety of one-on-one small group and interactive learning formats assist students to meet program and individual learning goals and to apply knowledge, skills and professional attitudes in their practice. As the most competitive degree program on the UCLA campus, the School of Nursing attracts the best and brightest students who will become leaders in transforming the profession of nursing.

The UCLA School of Nursing is approved by the Undergraduate and Graduate Councils of the Academic Senate of the University of California at Los Angeles. In addition, the pre-licensure (BS and MECN) and advanced practice master's programs are approved by the California Board of Registered Nursing. In 2011, the Commission on Collegiate Nursing Education (CCNE) accredited the existing bachelor's and master's degree programs for a term of 10 years, the highest that can be granted. The University of California, Los Angeles holds Western Association of Schools and Colleges accreditation. The school has 594 students including 238 undergraduate students, 356 graduate students, 47 tenured faculty, research faculty and instructors and 38 adjunct faculty and lecturers. It is a small school within a large research university, giving the dual advantage of personally knowing students while providing them with the best a research university has to offer.

Last updated July 1, 2018

The UCLA Department of Public Policy offers the Master of Public Policy (MPP). MPP students can pursue interdisciplinary Global Public Affairs and Leaders in Sustainability certificate programs. Joint degrees with Law, Management, Public Health, Medicine, and Social Welfare offer an even broader range of skill and expertise development. An undergraduate Minor in Public Affairs is also available. The school takes people who are passionate about making a difference in the world and give them the tools they need to do so. The master’s program combines the best of rigorous policy education with a flexibility and responsiveness that enables us to remain relevant in a rapidly changing world. A career in public service is no longer limited to working in government. By giving students a diversified tool kit of quantitative and analytical skills and the flexibility to design their own program of study— while drawing on all the resources of one of the world’s top research universities—the school produces graduates who are equipped to become real leaders in policy making, wherever that process takes place.

Last updated July 1, 2018

Recognized as one of the world's leading centers for the management of cerebral vascular disease, the UCLA Stroke Center treats simple and complex vascular disorders by incorporating recent developments in emergency medicine, stroke neurology, microneurosurgery, interventional neuroradiology, stereotactic radiology, neurointensive care, neuroanesthesiology, and rehabilitation neurology. Care is coordinated from the moment of first contact, in the emergency department or outpatient clinics, through acute treatment and neurological rehabilitation. The UCLA Stroke Center provides comprehensive diagnostic and therapeutic care of patients with disorders of blood vessels of the brain and spinal cord, including: ischemic stroke, transient ischemic attack, carotid stenosis, cerebral hemorrhage, aneurysms/subarachnoid hemorrhage, vascular malformations of the brain, and spinal vascular malformations. The UCLA Stroke Center opened one of the nation's first dedicated inpatient stroke units which offers state-of-the-art management of patients with brain infarction, brain hemorrhage and other cerebral vascular diseases. Other on-site facilities include a neurological intensive care unit, neurosurgical operating rooms, neuro-endovascular therapy suites, a clinical cerebral blood flow laboratory, stereotactic radiology rooms and an outpatient clinic.

Last updated July 1, 2018

The University of California President’s Postdoctoral Fellowship Program was established in 1984 to encourage outstanding women and minority Ph.D. recipients to pursue academic careers at the University of California. The current program offers postdoctoral research fellowships, professional development and faculty mentoring to outstanding scholars in all fields whose research, teaching, and service will contribute to diversity and equal opportunity at UC. The goal of the program is to provide research opportunity and career development for scholars whose work will enhance the diversity of the academic community at the University of California. Approximately 75% of UC President's Postdoctoral Fellows have received tenure track faculty appointments. Since 2003, over 100 former fellows received faculty appointments at University of California campuses.

Last updated July 1, 2018

The Undiagnosed Diseases Network (UDN) is an initiative to facilitate the diagnosis of conditions that have eluded diagnosis through the coordinated action of leading clinical and research centers. The UDN is a research study funded by the National Institutes of Health Common Fund. The UDN is made up of clinical and research centers across the United States working to improve diagnosis and care of patients with undiagnosed diseases. The UDN has two main goals: To provide answers for patients and families affected by mysterious conditions, and to learn more about rare and common diseases.

Last updated July 1, 2018